Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EMEA names first product recommended under ATMP Regulation

This article was originally published in Clinica

Executive Summary

The first product to pass through the new EU regulatory framework for Advanced Therapy Medicinal Products has been named. It is ChondroCelect, a cell-based medicine for cartilage repair of the femoral condyle of the knee. The product is manufactured by TiGenix, a Belgian company founded in 2000.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043681

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel